Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA.
BMC Cancer. 2012 Apr 3;12:136. doi: 10.1186/1471-2407-12-136.
Common measures of surgical quality are 30-day morbidity and mortality, which poorly describe breast cancer surgical quality with extremely low morbidity and mortality rates. Several national quality programs have collected additional surgical quality measures; however, program participation is voluntary and results may not be generalizable to all surgeons. We developed the Breast Cancer Surgical Outcomes (BRCASO) database to capture meaningful breast cancer surgical quality measures among a non-voluntary sample, and study variation in these measures across providers, facilities, and health plans. This paper describes our study protocol, data collection methods, and summarizes the strengths and limitations of these data.
We included 4524 women ≥18 years diagnosed with breast cancer between 2003-2008. All women with initial breast cancer surgery performed by a surgeon employed at the University of Vermont or three Cancer Research Network (CRN) health plans were eligible for inclusion. From the CRN institutions, we collected electronic administrative data including tumor registry information, Current Procedure Terminology codes for breast cancer surgeries, surgeons, surgical facilities, and patient demographics. We supplemented electronic data with medical record abstraction to collect additional pathology and surgery detail. All data were manually abstracted at the University of Vermont.
The CRN institutions pre-filled 30% (22 out of 72) of elements using electronic data. The remaining elements, including detailed pathology margin status and breast and lymph node surgeries, required chart abstraction. The mean age was 61 years (range 20-98 years); 70% of women were diagnosed with invasive ductal carcinoma, 20% with ductal carcinoma in situ, and 10% with invasive lobular carcinoma.
The BRCASO database is one of the largest, multi-site research resources of meaningful breast cancer surgical quality data in the United States. Assembling data from electronic administrative databases and manual chart review balanced efficiency with high-quality, unbiased data collection. Using the BRCASO database, we will evaluate surgical quality measures including mastectomy rates, positive margin rates, and partial mastectomy re-excision rates among a diverse, non-voluntary population of patients, providers, and facilities.
常用的手术质量评估指标为 30 天发病率和死亡率,但这两个指标并不能很好地描述乳腺癌手术质量,因为乳腺癌的发病率和死亡率非常低。几个国家的质量项目已经收集了其他手术质量评估指标;然而,项目参与是自愿的,结果可能无法推广到所有外科医生。我们开发了乳腺癌手术结果(BRCASO)数据库,以在非自愿样本中捕获有意义的乳腺癌手术质量评估指标,并研究这些指标在提供者、医疗机构和健康计划之间的差异。本文描述了我们的研究方案、数据收集方法,并总结了这些数据的优势和局限性。
我们纳入了 2003 年至 2008 年间诊断为乳腺癌且年龄≥18 岁的 4524 名女性。所有在佛蒙特大学或三个癌症研究网络(CRN)健康计划工作的外科医生进行初始乳腺癌手术的女性均有资格入选。从 CRN 机构中,我们收集了电子管理数据,包括肿瘤登记信息、乳腺癌手术的当前操作术语(Current Procedure Terminology)代码、外科医生、手术设施和患者人口统计学信息。我们通过病历摘录补充电子数据,以收集更多的病理和手术细节。所有数据均在佛蒙特大学手动摘录。
CRN 机构通过电子数据预先填写了 30%(22 个)元素。其余元素,包括详细的病理切缘状态以及乳房和淋巴结手术,需要通过病历摘录获取。平均年龄为 61 岁(范围为 20-98 岁);70%的女性被诊断为浸润性导管癌,20%为导管原位癌,10%为浸润性小叶癌。
BRCASO 数据库是美国最大的、多站点的有意义的乳腺癌手术质量数据研究资源之一。从电子管理数据库和手动病历审查中收集数据,在提高数据收集效率的同时,保证了数据的高质量和无偏性。我们将使用 BRCASO 数据库评估手术质量评估指标,包括乳房切除术率、阳性切缘率和部分乳房切除术再切除术率,这些指标是在一个多样化的、非自愿的患者、提供者和医疗机构人群中进行的。